119 related articles for article (PubMed ID: 863548)
1. Immunologic responses to a murine mammary adenocarcinoma. II. Monocyte effector activation by humoral factors.
Yamamura Y
Int J Cancer; 1977 May; 19(5):717-24. PubMed ID: 863548
[TBL] [Abstract][Full Text] [Related]
2. Immunological responses to a murine mammary adenocarcinoma: cytolysis by armed monocyte and by antibody-dependent cellular cytotoxicity.
Yamamura Y
Oncology; 1980; 37(1):6-11. PubMed ID: 7350556
[TBL] [Abstract][Full Text] [Related]
3. Immunologic responses to a murine mammary adenocarcinoma. I. Passive transfer of immunity by sera from tumor-bearing mice.
Yamamura Y; Virella G; Haskill JS
Int J Cancer; 1977 May; 19(5):707-16. PubMed ID: 68018
[TBL] [Abstract][Full Text] [Related]
4. ADCC effector cells in a murine adenocarcinoma. I. Evidence for blood-borne bone-marrow-derived monocytes.
Haskill JS
Int J Cancer; 1977 Sep; 20(3):432-40. PubMed ID: 903193
[TBL] [Abstract][Full Text] [Related]
5. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.
Haskill JS; Fett JW
J Immunol; 1976 Nov; 117(5 Pt.2):1992-8. PubMed ID: 993593
[TBL] [Abstract][Full Text] [Related]
6. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice.
DeLustro F; Haskill JS
J Natl Cancer Inst; 1980 Jan; 64(1):125-30. PubMed ID: 6928037
[TBL] [Abstract][Full Text] [Related]
7. Immunity to the T1699 murine mammary tumor. I. Thymic influence and long-term effect of irradiation on the humoral response.
Parthenais E; Haskill S
J Immunol; 1979 Sep; 123(3):1329-33. PubMed ID: 381522
[TBL] [Abstract][Full Text] [Related]
8. Immunologic factors influencing the intra-tumor localization of ADCC effector cells.
Haskill S; Parthenais E
J Immunol; 1978 Jun; 120(6):1813-7. PubMed ID: 659877
[TBL] [Abstract][Full Text] [Related]
9. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
Manson LA
Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
[No Abstract] [Full Text] [Related]
10. The antibody response to the T1699 murine adenocarcinoma: antibody class and subclass heterogeneity detected in serum and in situ.
Haskill JS; Radov LA; Fett JW; Parthenais E
J Immunol; 1977 Sep; 119(3):1000-5. PubMed ID: 19530
[TBL] [Abstract][Full Text] [Related]
11. Host responses within solid tumors: non-thymus-derived specific cytotoxic cells within a murine mammary adenocarcinoma.
Haskill JS; Yamamura Y; Radov L
Int J Cancer; 1975 Nov; 16(5):798-809. PubMed ID: 1081078
[TBL] [Abstract][Full Text] [Related]
12. Immunologic responses to a murine mammary adenocarcinoma: in vitro production of specific killer cells is dependent on active T lymphocytes.
Yamamura Y
J Immunol; 1978 Jan; 120(1):286-92. PubMed ID: 75226
[TBL] [Abstract][Full Text] [Related]
13. In situ Fc receptor-bearing cells in two murine tumors. II. Role in tumor immunity.
Korn JH; Haskill JS; Holden HT; Radov LA; Ritter FL
J Natl Cancer Inst; 1978 Jun; 60(6):1391-7. PubMed ID: 306442
[No Abstract] [Full Text] [Related]
14. Two-step mechanism of macrophage-mediated tumor lysis in vitro.
Yamazaki M; Shinoda H; Suzuki Y; Mizuno D
Gan; 1976 Oct; 67(5):741-5. PubMed ID: 797628
[TBL] [Abstract][Full Text] [Related]
15. Host immune potentiation of drug responses to a murine mammary adenocarcinoma. II. Effect of melphalan therapy on the host immune system.
Radov LA; Korn JH; Haskill JS
Int J Cancer; 1976 Nov; 18(5):630-8. PubMed ID: 992900
[TBL] [Abstract][Full Text] [Related]
16. Presence in mouse bone marrow of mediator-dependent cytotoxic effector cells against tumors.
Nakajima-Masuko Y; Okutomi T; Abe S; Mizuno D; Yamazaki M
Jpn J Exp Med; 1983 Oct; 53(5):227-33. PubMed ID: 6689597
[TBL] [Abstract][Full Text] [Related]
17. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
Huber SA; Lucas ZJ
J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
[No Abstract] [Full Text] [Related]
18. Collaboration between specific anti-tumor immunity and chemotherapeutic agents.
Yamamura Y; Proctor JW; Fischer BC; Harnaha JB; Mahvi TA
Int J Cancer; 1980 Mar; 25(3):417-23. PubMed ID: 6967055
[TBL] [Abstract][Full Text] [Related]
19. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
Blair PB; Lane MA; Mar P
J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of murine mammary adenocarcinoma cell subpopulations. In vitro and in vivo resistance to macrophage cytotoxicity and its association with metastatic capacity.
Yamamura Y; Fischer BC; Harnaha JB; Proctor JW
Int J Cancer; 1984 Jan; 33(1):67-72. PubMed ID: 6693196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
